Ozempic, Wegovy among drugs selected for Medicare's price negotiations
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare Part-D for price negotiations, the next round of negotiations under the Inflation Reduction Act passed by President Joe Biden in 2022.
Trump’s executive order halts an effort to cap the copayment for generic medications at $2 for Medicare beneficiaries.
Medicare Payment Advisory Commission recommends tying physician payment update to care cost growth; AMA calls for Congress to act on analysis.
Under legislation passed in 2022 called the Inflation Reduction Act, Medicare was allowed for the first time to negotiate prices with drug companies on a limited number of medications.
In 2025, more than 3 million seniors are going to save thousands of dollars because of a new spending limit on prescription drugs. It's unclear whether the Trump Administration will keep the law.
Hospitals are also seeing higher uncompensated care as individuals lose Medicaid coverage or decide not to purchase health insurance. If there are changes to the health insurance exchanges, more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback